US FDA approves new immunotherapy for rectal cancer
The US FDA approved a new immunotherapy for certain rectal cancer patients, allowing some to avoid surgery and chemotherapy.
The US FDA approved a new immunotherapy for certain rectal cancer patients, allowing some to avoid surgery and chemotherapy.